Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials

Published:2023-08 Issue:2 Volume:89 Page:423-425
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Spencer Riley K.,Jin Joy Q.,Elhage Kareem G.,Davis Mitchell S.,Hakimi Marwa,Bhutani Tina,Liao Wilson

Funder

University of California

Novartis Pharmaceuticals Corporation

National Psoriasis Foundation

Pfizer

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. The efficacy of biologic therapy for the management of palmoplantar psoriasis and palmoplantar pustulosis: a systematic review;Sanchez;Dermatol Ther,2017

2. MetaInsight: an interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta;Owen;Res Syn Meth,2019

3. Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials;Dias;Med Decis Making,2013

4. Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis;Chung;J Am Acad Dermatol,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis;Journal of Dermatological Treatment;2024-09-10

2. Disease heterogeneity and molecular classification of inflammatory palmoplantar diseases;Journal of Allergy and Clinical Immunology;2024-07

3. Targeted immunotherapy for moderate-to-severe palmoplantar pustulosis: A network meta-analysis of randomized controlled trials;Journal of the American Academy of Dermatology;2024-07

4. Treatment of palmoplantar psoriasis with oral roflumilast: a case series;Clinical and Experimental Dermatology;2024-06-26

5. Spesolimab: Is it a new treatment target in palmoplantar pustulosis?;International Journal of Rheumatic Diseases;2024-05